The Fridley-based company makes cardiovascular, cardiac rhythm, neurological, spinal, diabetes and surgical medical device technologies and therapies.
Delayed Price / Updated: /
|52 Week High||67.11|
|52 Week Low||53.33|
|Today's Range||64.07 - 62.18|
A federal judge in Minneapolis has pushed forward a lawsuit involving Medtronic Inc.’s problematic Infuse bone growth product that could complicate the company’s controversial $43 billion...
Health care supply company Covidien PLC will remain mostly intact as a separate division of Medtronic Inc. after the proposed $43 billion deal to merge the two companies under a new Irish parent.With...
One of the ironies of this season of tax inversions is that the big Minnesota company that seems hellbent on completing one already pays less than half the 35 percent statutory federal tax rate.That...
Medtronic is pushing ahead with a controversial “tax inversion” deal that could save billions in taxes, despite recent legal changes that aimed to make such maneuvers less attractive.The...
Another step has been added to the development process for medical devices: preventing cyberattacks.The U.S. Food and Drug Administration on Wednesday finalized guidelines strongly urging...
|Current year rank||13|
|Current year compensation||$8,331,159|
|Percent change of the CEO||33.0|
The deal will move Medtronic’s executive headquarters to Dublin, where it will enjoy substantial tax advantages.
Minnesota Topics are a comprehensive collection of Star Tribune content on select people, places and companies.